October 2016 Issue Table Of Contents

From The Editor

• Social Media Fans Flames Of Biopharma Blunders

Feature Articles

• Why Otsuka Diversified Into Digital Health
• Are You Ready To Fund Your Life Sciences Startup?

The Enterprisers

• NOVAVAX: Scouting Past The Long Trail To Market

Capitol Perspectives

• Congress’ Abdication Of Authority Of Medicare To The Executive

Companies To Watch

• ViewPoint Therapeutics

CEO Corner

• Biotechnology: The Hope For Rare Diseases

Inside The Industry

• What GSK Learned From Using Mobile And Wearable Technologies
• Big Pharma Goes Small With Moves Into Incubator Space
• 9 Biotech Valuation Enhancers: Preparing For Big Pharma Due Diligence

Leadership Lessons

• Hiring Millennials A Balancing Act

Ask The Board

• What Do You Say To Those Who Are Looking At A Job Description/Career That Requires Prior Experience?
• What Simple Changes To Biopharma Manufacturing Could Be Quickly Implemented That Would Have Almost An Immediate Impact On The Lowering Of Drug Prices?
• What Big Biopharma Companies Do You Find Most Exciting And Why?